[1] SCHMIDT E P, LEE W L, ZEMANS R L, et al. On,around, and through: neutrophil endothelial interactions in innateimmunity[J]. Physiology, 2011, 26(5):334-347.
[2] HICKEY M J, KUBES P. Intravascular immunity:the host-pathogen encounter in blood vessels[J]. Nat Rev Immunol, 2009,9(5):364-375.
[3] LEY K, LAUDANNA C, CYBULSKY M I, et al. Getting to the site of inflammation: the leukocyte adhesion cascade updated[J]. Nat Rev Immunol, 2007,7(9):678-689.
[4] JOSEPHS B,CASTRILLOA,LAFFITTEB A, et al. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors[J]. Nat Med, 2003;9(2):213-219.
[5] McDONALD B. Intravascular danger signals guide neutrophils to sites of sterile inflammation[J]. Science,2010,330:362-366.
[6] SUMMERS C, RANKIN S M, CONDLIFFE A M, et al. Neutrophil kinetics in health and disease[J]. Trends Immunol, 2010, 31:318-324.
[7] GORDY C, PUA H, SEMPOWSKI G D, et al.Regulation of steady-state neutrophil homeostasis by macrophages[J]. Blood, 2011,117:618-629.
[8] 智宏, 任利群, 马根山,等.冠心病合并代谢综合征者炎症因子水平与冠脉病变程度的研究[J].东南大学学报:医学版,2009,28(1):10-12.
[9] SOEHNLEIN O, LINDBOM L. Phagocyte partnership during the onset and resolution of inflammation[J]. Nat Rev Immunol, 2010, 10:427-439.
[10] 秦远英, 林勇. 阻塞性睡眠呼吸暂停低通气综合征、骨桥蛋白及炎症反应三者之间的关系[J]. 东南大学学报:医学版, 2012,31(3):369-372.
[11] WEISS S J. Tissue destruction by neutrophils[J]. N Engl J Med, 1989,320(6):365-376.
[12] PADMANABHAN J, GONZALEZ A L. The effects of extracellular matrix proteins on neutrophil-endothelial interaction-a roadway to multiple therapeutic opportunities[J]. Yale J Biol Med,2012, 85(2):167-185
[13] CALL D R, NEMZEK J A, EBONG S J, et al.Ratio of local to systemic chemokine concentrations regulates neutrophil recruitment[J]. Am J Pathol, 2001,158(2):715-721.
[14] MICHELSEN K S, ARDITI M. Toll-like receptors and innate immunity in gut homeostasis and pathology[J] Curr Opin Hematol, 2007, 14(1):48-54.
[15] RACHMILEWITZ D, KATAKURA K, KARMELI F, et al.Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis[J]. Gastroenterology, 2004, 126(2):520-528.
[16] LI W, NAVA R G, BRIBRIESCO A C,et al. Intravital2-photon imaging of leukocytetrafficking in beating heart[J]. J Clin Invest, 2012, 122(7):2499-2508.
[17] AGOSTINI L, MARTINON F, BURNS K,et al. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder[J]. Immunity, 2004,20(3):319-325.
[18] BLOMGRAN R, P-BRODIN V, VERMA D, et al. Common genetic variations in the NALP3 inflammasome are associated with delayed apoptosis of human neutrophils[J].PLoS One, 2012,7(3):e31326.
[19] ASEA A, KRAEFT S K, KURT-JONES E A,et al.HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine[J]. Nat Med, 2000,6(4):435-442.
[20] CASTOLDI A, BRAGA T T, CORREA-COSTA M, et al. TLR2, TLR4 and the MYD88 signaling pathway are crucial for neutrophil migration in acute kidney injury induced by sepsis[J]. PloS One, 2012, 7(5):e37584.
[21] FRASCH S C, FERNANDEZ-BOYANAPALLI R F, BERRY K Z,et al. Signaling via macrophage G2A enhances efferocytosis of dying neutrophils by augmentation of RAC activity[J]. J Biol Chem, 2011, 286(14):12108-12122.
[22] LAGASSE E, WEISSMAN I L. bcl-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages[J]. J Exp Med, 1994, 179:1047-1052.
[23] SUMMERS C, RANKIN S M, CONDLIFFE A M,et al. Neutrophil kinetics in health and disease[J]. Trends Immunol, 2010, 31:318-324.
[24] PAPATHANASSOGLOU E D, MOYNIHAN J A, MCDERMOTT M P, et al. Expression of Fas(CD95) and Fas ligand on peripheral blood mononuclear cells in critical illness and association with multiorgan dysfunction severity and survival[J]. Crit Care Med, 2001, 29(4):709-718.
[25] DAIGLE I, SIMON H U. Critical role for cas-pases 3 and 8 in neutrophil but not eosinophil apoptosis[J]. Int Arch Allergy Immunol, 2001,126:147-156.
[26] PAUNEL-GÖRGVLV A, KIRICHEVSKA T, LÖGTERS T, et al. Molecular mechanisms underlying delayed apoptosis in neutrophils from multiple trauma patients with and without sepsis[J]. Mol Med, 2012,18:325-335.
[27] VANDERLAAN P A, REARDON C A. Thematic re-view series: the immune system and athero-genesis. The unusual suspects: an overview of the minor leukocyte populations in athero-sclerosis[J]. J Lipid Res, 2005, 46(5):829-838.
[28] DEJONCKHEERE E, VANDENBROUCKE R E, LIBERT C. Matrix metalloproteinase8 has a central role in inflammatory disorders and cancer progression[J]. Cytokine Growth Factor Rev, 2011,22: 73-81.
[29] GONZÁLEZ-LPEZ A, AGUIRRE A, LPEZ-ALONSO I, et al. MMP-8 deficiency increases TLR/RAGE ligands S100A8 and S100A9 and exacerbates lung inflammation during endotoxemia[J]. PloS One, 2012, 7(6):e39940.
[30] YAMAGUCHI K, SHIRAKABE K, SHIBUYA H, et al. Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction[J]. Science, 1995,270: 2008-2011.
[31] EFTYCHI C, KARAGIANNI N, ALEXIOU M, et al.Myeloid TAKI acts as a negative regulator of the LPS response and mediates resistance to endotoxemia[J]. PloS One, 2012, 7(2):e31550.
[32] STARNES T W,HUTTENLOCHER A.Neutrophil reverse migration becomes transparent with zebrafish[J].Adv Hematol, 2012,2012:398640. |